Ilsung IS Co Ltd

Business Summary Ilsung IS Co Ltd is a pharmaceutical company that develops and sells prescription drugs, primarily in the South Korean market. --- # Classification Summary Ilsung IS Co Ltd is classified under the Healthcare economic sector, within the Pharmaceuticals & Medical Research business sector, and the Pharmaceuticals industry, with a classification confidence of 0.92. --- # Narrative Ilsung IS Co Ltd has a strong liquidity position, with a current ratio of 17.47, indicating that the company holds significantly more current assets than current liabilities. The company's cash and equivalents amount to 120,279,901,120 KRW, which is a substantial portion of its total assets of 403,009,986,640 KRW. Despite this, the company reported a negative operating income of -6,160,588,840 KRW and a net income of 1,165,834,880 KRW, suggesting that while it is generating some profit, it is not sufficient to cover its operating costs. The company's profitability metrics are below industry norms. Its return on equity (ROE) is 0.003, and its return on assets (ROA) is 0.0029, both of which are significantly lower than the typical performance of companies in the pharmaceutical industry. The price-to-book ratio of 0.37 indicates that the company's market value is lower than its book value, which may suggest undervaluation or concerns about future earnings potential. Ilsung IS Co Ltd's revenue is concentrated in a single geographic market, primarily South Korea, as disclosed in its financial segments. The company does not report revenue from multiple regions, which could expose it to regional economic or regulatory risks. There is no indication of diversified product lines or international operations in the provided data. The company's growth trajectory appears to be constrained. The operating cash flow of 3,881,172,100 KRW is positive, but the free cash flow is negative at -4,155,815,720 KRW, indicating that the company is spending more on capital expenditures than it is generating in cash from operations. The capital expenditure of -2,175,584,600 KRW suggests that the company is investing in its operations, but the negative free cash flow indicates that these investments are not yet generating sufficient returns. The risk assessment for Ilsung IS Co Ltd indicates low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio is 0.0, which is favorable and suggests that the company is not heavily leveraged. However, the negative operating income and the high price-to-earnings ratio of 124.09 may indicate that the company is not currently a strong investment. Recent events and filings do not show any significant changes in the company's financial or operational status. The company's financial statements do not indicate any recent major events that would significantly impact its operations or financial health. The absence of recent dilution or liquidity issues suggests that the company is maintaining a stable capital structure. --- # Key Takeaways - Ilsung IS Co Ltd has a strong liquidity position with a current ratio of 17.47 and significant cash reserves. - The company's profitability metrics, including ROE and ROA, are below industry norms, indicating suboptimal performance. - Revenue is concentrated in a single geographic market, exposing the company to regional risks. - The company is investing in capital expenditures, but the negative free cash flow suggests that these investments are not yet generating returns. - The company has low liquidity and dilution risks, with no immediate filing-based flags detected. --- # Rationales ```json { "margin_outlook_rationale": "The company's operating margin is negative, indicating that it is not covering its operating costs, which suggests a poor outlook for margin improvement.", "rd_outlook_rationale": "There is no specific information provided about the company's research and development activities or their expected impact on future performance.", "capex_outlook_rationale": "The company is investing in capital expenditures, but the negative free cash flow indicates that these investments are not yet generating returns.", "revenue_outlook_rationale": "The company's revenue is concentrated in a single geographic market, which could limit its growth potential and expose it to regional economic or regulatory risks.", "segment_outlook": {}, "dilution_sources": [], "dilution_near_term_probability": "low", "dilution_expected_timeframe": "no near-term pressure", "concentration_risk": "high", "regulatory_risk": "low", "liquidity_risk_rationale": "The company has a strong liquidity position with a current ratio of 17.47 and significant cash reserves, which reduces liquidity risk.", "credit_risk_rationale": "The company's debt-to-equity ratio is 0.0, indicating that it is not heavily leveraged, which reduces credit risk." } ``` --- # Inversion (DS-6) ```json { "bull_to_bear_signals": [ { "signal_id": "negative-operating-income", "signal": "Operating income becomes negative", "monitorable_field": "financial_snapshot.operating_income", "threshold": "value < 0", "rationale": "A negative operating income indicates that the company is not covering its operating costs, which could lead to a decline in stock price." }, { "signal_id": "free-cash-flow-negative", "signal": "Free cash flow remains negative", "monitorable_field": "financial_snapshot.free_cash_flow", "threshold": "value < 0", "rationale": "A negative free cash flow indicates that the company is spending more on capital expenditures than it is generating in cash from operations, which could lead to a decline in stock price." } ], "bear_to_bull_signals": [ { "signal_id": "positive-operating-income", "signal": "Operating income becomes positive", "monitorable_field": "financial_snapshot.operating_income", "threshold": "value > 0", "rationale": "A positive operating income indicates that the company is covering its operating costs, which could lead to an increase in stock price." }, { "signal_id": "positive-free-cash-flow", "signal": "Free cash flow becomes positive", "monitorable_field": "financial_snapshot.free_cash_flow", "threshold": "value > 0", "rationale": "A positive free cash flow indicates that the company is generating more cash from operations than it is spending on capital expenditures, which could lead to an increase in stock price." } ] } ``` --- # Self Scoring ```json { "business_understanding_score": 0.85, "economics_quality_score": 0.75, "ten_year_visibility_score": 0.65, "competitive_landscape_visibility_score": 0.70 } ```